Ana Herrero

1.3k citations
41 papers · 591 indexed · h-index 14
Topics
Ovarian cancer diagnosis and treatment (11 papers)Glioma Diagnosis and Treatment (8 papers)PARP inhibition in cancer therapy (7 papers)
Partner nations
SpainItalyUnited Kingdom

In The Last Decade

Ana Herrero

37 papers receiving 573 citations

Peers

Ana Herrero
Comparison fields: 5 of 82
  • Oncology 217
  • Cancer Research 137
  • Pulmonary and Respiratory Medicine 125
  • Molecular Biology 112
  • Genetics 112
Replace Mona El-Hashimy with:
Mona El-Hashimy United States
Raffaele Cozza Italy
Xiangrong Cui China
Henrik Kiær Denmark
Petra Kleiblová Czechia
Monica Taborelli Italy
Tomoyo Yasui Japan
M. Bianchi Italy
Ayman Elnemr Japan
Katarína Kaľavská Slovakia
Ana Herrero relative to Mona El-Hashimy United States Mona El-Hashimy's profile →
Citations per field
00.5×1.5×
Mona El-Hashimy · 1×
Citations per year

Countries citing papers authored by Ana Herrero

Since Specialization
Citations

This map shows the geographic impact of Ana Herrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Herrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Herrero more than expected).

Fields of papers citing papers by Ana Herrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Herrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Herrero. The network helps show where Ana Herrero may publish in the future.

Co-authorship network of co-authors of Ana Herrero

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Herrero. A scholar is included among the top collaborators of Ana Herrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Herrero. Ana Herrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 6
3 1
4 1
5 2
6 48
7 9
8 28
9 10
10 19
11 69
12 32
13 25
14 15
15 90
16
Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study.
61
17 2
18 20
19 9
20
Cartografía de España en la Biblioteca Nacional (siglos XVI al XIX)
1

About Ana Herrero

Ana Herrero is a scholar working on Reproductive Medicine, Genetics and Oncology, having authored 41 papers that have together received 591 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (11 papers), Glioma Diagnosis and Treatment (8 papers) and PARP inhibition in cancer therapy (7 papers). The work is most often cited by research in Reproductive Medicine (109 citations), Genetics (112 citations) and Cancer Research (137 citations). Ana Herrero has collaborated with scholars based in Spain, Italy and United Kingdom. Frequent co-authors include Antonio Antón, Carmen Balañá, Antonio Casado, Javier Martínez‐Trufero, Á. Artal, Teresa Puértolas, Laura García‐Estévez, José Fortes, Francisco S. N. Lobo and Jesús Florián. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026